المؤلفون: Mina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, Jeanett Friis Rohde, Anja Ussing, Sabrina Mai Nielsen, Robin Christensen, Jean-Jacques Body, Maria Luisa Brandi, Adolfo Diez-Perez, Peyman Hadji, Muhammad Kassim Javaid, Willem Frederik Lems, Xavier Nogues, Christian Roux, Salvatore Minisola, Andreas Kurth, Thierry Thomas, Daniel Prieto-Alhambra, Serge Livio Ferrari, Bente Langdahl, Bo Abrahamsen

المساهمون: Rheumatology, AII - Inflammatory diseases, AMS - Musculoskeletal Health, AMS - Tissue Function & Regeneration, Medical Informatics

المصدر: BMJ (Clinical research ed.), 381:e068033. BMJ Publishing Group
Händel, M N, Cardoso, I, von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J-J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ (Clinical research ed.), vol. 381, e068033, pp. e068033 . https://doi.org/10.1136/bmj-2021-068033
BMJ. BMJ Publishing Group
Händel, M N, Cardoso, I, Von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ, vol. 381, e068033 . https://doi.org/10.1136/bmj-2021-068033

مصطلحات موضوعية: Osteoporotic Fractures/prevention & control, Network Meta-Analysis, General Medicine, Postmenopause, Diphosphonates/adverse effects, Osteoporosis, Postmenopausal/complications, Humans, Spinal Fractures, Female, Bone Density Conservation Agents/adverse effects, Denosumab/adverse effects, Risk Reduction Behavior, Osteoporosis/drug therapy, Randomized Controlled Trials as Topic, Receptor, Parathyroid Hormone, Type 1

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fe144b36a98726531161e01f3c5cae
https://research.vumc.nl/en/publications/fa39a0b8-bbaa-439b-be56-ad77e3290541